510(k) K191716
K191716 is an FDA 510(k) premarket notification submitted by Pear Therapeutics, Inc. for the device "Somryst". The FDA issued a decision of Substantially Equivalent on March 23, 2020. The device falls under product code QVO (Computerized Behavioral Therapy Device For Insomnia), a Class II device regulated under 21 CFR 882.5801. Pear Therapeutics, Inc. has at least 2 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 23, 2020
- Date Received
- June 26, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Computerized Behavioral Therapy Device For Insomnia
- Device Class
- Class II
- Regulation Number
- 882.5801
- Review Panel
- NE
- Submission Type
The device is intended to provide cognitive behavioral therapy to treat insomnia.